Many systematic reviews are inconclusive and reinforce the message that there is clinical uncertainty. Phil Alderson and Ian Roberts argue that journals should make a point of publishing such reviews rather than waiting for reviews that show marked benefit or harm. Some experts disagree, however, but we failed to persuade them to commit their views to print. Studies with dramatic findings make interesting reading. Journal editors understandably want to publish articles that their readers will enjoy. This is one cause of publication bias, where research with less dramatic results tends to be published in journals with a smaller circulation, if indeed it is published at all. Systematic reviews are no less vulnerable to this bias than other types of research. Should journals resist this pressure and make a point of publishing systematic reviews even if all they show is continuing clinical uncertainty? The answer will depend on the importance we attach to demonstrating uncertainty in medical practice. #### Summary points Denying uncertainty does not benefit patients and may increase health service costs More large scale randomised trials need to be conducted based on the “uncertainty principle” Systematic reviews with more dramatic results tend …
No takes yet. Share an insight, caveat, or question.
Priscilla Alderson (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: